Author: vincenzo

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells: Cell Reports Medicine

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells: Cell Reports Medicine
— Read on www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00203-2

Yet another study confirming both B and T cell long lasting and stable immunity in Covid-19 recovered patients. Those who have had Covid-19 DO NOT NEED the vaccine. Yet in many countries they are being threatened with #GreenPass, which can only be kept “Green” with regular doses of vaccine.

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals | Scientific Reports

The COVID-19 pandemic has revealed a range of disease phenotypes in infected patients with asymptomatic, mild, or severe clinical outcomes, but the mechanisms that determine such variable outcomes remain unresolved. In this study, we identified immunodominant CD8 T-cell epitopes in the spike antigen using a novel TCR-binding algorithm. The predicted epitopes induced robust T-cell activation in unexposed donors demonstrating pre-existing CD4 and CD8 T-cell immunity to SARS-CoV-2 antigen. The T-cell reactivity to the predicted epitopes was higher than the Spike-S1 and S2 peptide pools in the unexposed donors. A key finding of our study is that pre-existing T-cell immunity to SARS-CoV-2 is contributed by TCRs that recognize common viral antigens such as Influenza and CMV, even though the viral epitopes lack sequence identity to the SARS-CoV-2 epitopes. This finding is in contrast to multiple published studies in which pre-existing T-cell immunity is suggested to arise from shared epitopes between SARS-CoV-2 and other common cold-causing coronaviruses. However, our findings suggest that SARS-CoV-2 reactive T-cells are likely to be present in many individuals because of prior exposure to flu and CMV viruses.
— Read on www.nature.com/articles/s41598-021-92521-4

The Giant Company: a piece of tech for the image of the beast?

I have before looked at many passages in the book of Revelation as requiring advanced technology. After all, John the Apostle had a limited vocabulary with which render his visions. But one passage I never actually linked to a technological advancement is this:

”And it was given to him to give breath to the image of the beast, so that the image of the beast would even speak and cause as many as do not worship the image of the beast to be killed”

Revelation 13:15

This technology—or some refined form of it—could actually provide the basis for the moving and speaking image of the beast that the world will be asked to worship.

“The Spike protein is itself toxic and dangerous for humans,” says Professor Bridle

“Nous avons fait une erreur”. Dans une interview rĂ©cente avec la journaliste Alex Pierson, le professeur Byram Bridle, spĂ©cialiste en immunologie virale, dĂ©clare que ces nouvelles recherches et travaux l’ont menĂ© Ă  faire des dĂ©couvertes importantes sur le virus et en particulier la protĂ©ine Spike. Cette protĂ©ine est celle qui a fait l’objet de nombreux travaux notamment sur les vaccins Ă  ARN messagers.
— Read on www.francesoir.fr/societe-sante/nous-avons-fait-une-erreur-la-proteine-spike-est-elle-meme-toxique-et-dangereuse-pour

JCI Insight – A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

JCI Insight – A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
— Read on insight.jci.org/articles/view/146316


The “new virus”. I predicted pre existing immunity to it ages ago. Both B and T cells immunity, even cross reactive, is now a fact. The mass vaccination programme makes no sense, unless other reasons for it are taken into account.